Systemic Corticosteroids for Treating Respiratory Diseases: Less Is Better, but… When and How Is It Possible in Real Life?

Abstract Systemic corticosteroids (CSs), a keystone in pulmonology, are drugs with strong antiinflammatory activity. They are cheap, easily available, and accessible, but with common and serious side effects. Moreover, the use of exogenous CSs may suppress the hypothalamic–pituitary–adrenal (HPA) ax...

Full description

Bibliographic Details

Published in:	Pulmonary Therapy
Main Authors:	Andrea S. Melani, Sara Croce, Lucia Cassai, Giusy Montuori, Gaia Fabbri, Maddalena Messina, Magda Viani, Elena Bargagli
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2023-06-01
Subjects:	Corticosteroid Glucocorticoid Adrenal insufficiency COVID-19 ARDS Asthma
Online Access:	https://doi.org/10.1007/s41030-023-00227-x